Related references
Note: Only part of the references are listed.Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Jason Boyang Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Synthesis and SAR studies of marine natural products ma'edamines A, B and their analogues
Sanjay Saha et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Stabilization of MDA-7/IL-24 for colon cancer therapy
Shili Xu et al.
CANCER LETTERS (2013)
gp130: a promising drug target for cancer therapy
Shili Xu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis
Tzu-Hua Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer
Shili Xu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Loss of Survivin in the Prostate Epithelium Impedes Carcinogenesis in a Mouse Model of Prostate Adenocarcinoma
Helty Adisetiyo et al.
PLOS ONE (2013)
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
A. W. Tolcher et al.
ANNALS OF ONCOLOGY (2012)
Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression
Jing Zhu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties
Li-Fan Zeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Bikash Debnath et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation
Zelan Wei et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
Shili Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Monoamine Oxidase A gene promoter repeat and prostate cancer risk
Thomas A. White et al.
PROSTATE (2012)
Survivin in Solid Tumors: Rationale for Development of Inhibitors
David N. Church et al.
CURRENT ONCOLOGY REPORTS (2012)
Small-Molecule Inhibitors of p53-MDM2 Interaction: the 2006-2010 Update
Melissa Millard et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Targeting survivin in cancer: the cell-signalling perspective
Jagat R. Kanwar et al.
DRUG DISCOVERY TODAY (2011)
Guidelines for the welfare and use of animals in cancer research
P. Workman et al.
BRITISH JOURNAL OF CANCER (2010)
Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery
Roppei Yamada et al.
CANCER BIOLOGY & THERAPY (2010)
Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity
Haijuan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeting monoamine oxidase A in advanced prostate cancer
Vincent Flamand et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
Shivanni Kummar et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Combination effects of SC144 and cytotoxic anticancer agents
Takashi Oshima et al.
ANTI-CANCER DRUGS (2009)
Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells
Hongjuan Zhao et al.
BMC MEDICAL GENOMICS (2009)
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Mohamed S. Arredouani et al.
CLINICAL CANCER RESEARCH (2009)
Synthesis and biological evaluation of novel hydrazide based cytotoxic agents
Fedora Grande et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Prostate Cancer Regulatory Networks
Dario C. Altieri et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells
Hongjuan Zhao et al.
DIFFERENTIATION (2008)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The Significance of Monoamine Oxidase-A Expression in High Grade Prostate Cancer
Donna M. Peehl et al.
JOURNAL OF UROLOGY (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
Takahito Nakahara et al.
CANCER RESEARCH (2007)
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides
Fedora Grande et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Discovery of a novel small molecule binding site of human survivin
Michael D. Wendt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structural, functional and therapeutic biology of survivin
N. K. Sah et al.
CANCER LETTERS (2006)
A molecular correlate to the Gleason grading system for prostate adenocarcinoma
Lawrence True et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Expression signature of the mouse prostate
IM Berquin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery
XY Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
SY Wang et al.
CANCER CELL (2003)
Pten dose dictates cancer progression in the prostate
LC Trotman et al.
PLOS BIOLOGY (2003)
Gene expression analysis of prostate cancers
JH Luo et al.
MOLECULAR CARCINOGENESIS (2002)
Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression
MH Vaarala et al.
LABORATORY INVESTIGATION (2000)
Share Paper
